Observational studyEuropean journal of haematology2025

Clinical Efficacy of Isatuximab Plus Carfilzomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients.

Danilo De Novellis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.